We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $15.1B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
AUM
$3.54B
AUM Growth
+$107M
Cap. Flow
+$179M
Cap. Flow %
5.05%
Top 10 Hldgs %
20.31%
Holding
4,474
New
404
Increased
1,575
Reduced
1,479
Closed
707
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYLN icon
3576
Hyliion Holdings
HYLN
$627M
$146 ﹤0.01%
4
-28
-88% -$56
MFM
3577
Aberdeen Municipal Income Fund
MFM
$221M
$146 ﹤0.01%
83
+56
+207% +$306
EXFY icon
3578
Expensify
EXFY
$235M
$145 ﹤0.01%
+167
New +$198
EVI icon
3579
EVI Industries
EVI
$185M
$144 ﹤0.01%
7
-84
-92% -$1.88K
PINE
3580
Alpine Income Property Trust
PINE
$344M
$144 ﹤0.01%
8
+5
+167% +$93
ZURA icon
3581
Zura Bio
ZURA
$548M
$143 ﹤0.01%
24
EML icon
3582
Eastern Company
EML
$158M
$142 ﹤0.01%
+7
New +$133
LWLG icon
3583
Lightwave Logic
LWLG
$846M
$141 ﹤0.01%
20
CZWI icon
3584
Citizens Community Bancorp
CZWI
$203M
$139 ﹤0.01%
+10
New +$184
MJ icon
3585
Amplify Alternative Harvest ETF
MJ
$117M
$139 ﹤0.01%
7
+1
+17% +$26
PBFS icon
3586
Pioneer Bancorp
PBFS
$426M
$139 ﹤0.01%
+6
New +$84
AISP
3587
Airship AI Holdings
AISP
$72M
$136 ﹤0.01%
+60
New +$170
AVNW icon
3588
Aviat Networks
AVNW
$256M
$136 ﹤0.01%
6
+2
+50% +$48
FPI
3589
Farmland Partners
FPI
$447M
$135 ﹤0.01%
+12
New +$138
LUCD icon
3590
Lucid Diagnostics
LUCD
$189M
$135 ﹤0.01%
+117
New +$149
ACEL icon
3591
Accel Entertainment
ACEL
$964M
$131 ﹤0.01%
12
-11
-48% -$124
OVID icon
3592
Ovid Therapeutics
OVID
$547M
$127 ﹤0.01%
57
AMBQ
3593
Ambiq Micro
AMBQ
$1.39B
$127 ﹤0.01%
+5
New +$149
TLYS icon
3594
Tilly's
TLYS
$121M
$122 ﹤0.01%
+30
New +$61
PLX icon
3595
Protalix BioTherapeutics
PLX
$205M
$120 ﹤0.01%
55
+16
+41% +$40
SMRT icon
3596
SmartRent
SMRT
$257M
$119 ﹤0.01%
79
+55
+229% +$93
RNAC icon
3597
Cartesian Therapeutics
RNAC
$290M
$117 ﹤0.01%
+19
New +$135
CRBU icon
3598
Caribou Biosciences
CRBU
$174M
$116 ﹤0.01%
65
+4
+7% +$7
PROK icon
3599
ProKidney
PROK
$382M
$116 ﹤0.01%
61
-4
-6% -$8
MKTW icon
3600
MarketWise
MKTW
$50.3M
$112 ﹤0.01%
6
+5
+500% +$77

Similar funds

Arax Advisory Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Arax Advisory Partners held 4,474 positions worth $3.54B, up 3.1% from $3.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arax Advisory Partners deployed $179M of net new capital in Q1 2026, opening 404 new positions and adding to 1,575 existing holdings. Its largest new stake was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 68% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $32.9M trimmed.

  • Arax Advisory Partners's largest Q1 2026 buy was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.
  • Arax Advisory Partners added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $59M increase.
  • Arax Advisory Partners's biggest Q1 2026 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $32.9M.
  • Arax Advisory Partners fully exited Willis Towers Watson in Q1 2026, selling an estimated $746K.
  • Arax Advisory Partners's ten largest holdings make up 20% of its $3.54B portfolio in Q1 2026.
  • Arax Advisory Partners opened 404 new positions and closed 707 in Q1 2026.
  • Arax Advisory Partners's portfolio value rose 3.1% quarter-over-quarter to $3.54B.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.